A

Avalon Globocare Corp
NASDAQ:ALBT

Watchlist Manager
Avalon Globocare Corp
NASDAQ:ALBT
Watchlist
Price: 1.25 USD
Market Cap: 5.3m USD

Avalon Globocare Corp
Operating Income

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Avalon Globocare Corp
Operating Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
A
Avalon Globocare Corp
NASDAQ:ALBT
Operating Income
-$17m
CAGR 3-Years
-32%
CAGR 5-Years
-3%
CAGR 10-Years
N/A
Quest Diagnostics Inc
NYSE:DGX
Operating Income
$1.6B
CAGR 3-Years
-6%
CAGR 5-Years
-1%
CAGR 10-Years
4%
CVS Health Corp
NYSE:CVS
Operating Income
$10.8B
CAGR 3-Years
-13%
CAGR 5-Years
-6%
CAGR 10-Years
2%
Cigna Corp
NYSE:CI
Operating Income
$10B
CAGR 3-Years
6%
CAGR 5-Years
3%
CAGR 10-Years
11%
Laboratory Corporation of America Holdings
NYSE:LH
Operating Income
$1.4B
CAGR 3-Years
-11%
CAGR 5-Years
-8%
CAGR 10-Years
3%
Guardant Health Inc
NASDAQ:GH
Operating Income
-$433.7m
CAGR 3-Years
4%
CAGR 5-Years
-18%
CAGR 10-Years
N/A
No Stocks Found

Avalon Globocare Corp
Glance View

Market Cap
5.1m USD
Industry
Health Care

Avalon GloboCare Corp. is a holding company, which engages in the development of biotechnology and the provision of healthcare services. The company is headquartered in Freehold, New Jersey and currently employs 5 full-time employees. The company went IPO on 2016-02-22. The firm is focused on the fields of cellular immunotherapy, including CAR-T/NK; exosome technology (ACTEX), and COVID-19-related vaccine and therapeutics through its subsidiaries. The company operates through two business segments: real property operating segment and medical related consulting services segment. The firm also provides strategic advisory and outsourcing services to facilitate and improve its clients’ growth and development, as well as competitiveness in healthcare and CellTech industry markets. Its downstream medical team and facility consists of affiliated hospital networks and experts specialized in hematology, oncology, cellular immunotherapy, hematopoietic stem/progenitor cell transplant, as well as regenerative therapeutics. Its clinical programs include AVA-001, ACTEX, FLASH-CAR, and AVA-Trap.

ALBT Intrinsic Value
1.01 USD
Overvaluation 19%
Intrinsic Value
Price
A

See Also

What is Avalon Globocare Corp's Operating Income?
Operating Income
-17m USD

Based on the financial report for Sep 30, 2025, Avalon Globocare Corp's Operating Income amounts to -17m USD.

What is Avalon Globocare Corp's Operating Income growth rate?
Operating Income CAGR 5Y
-3%

Over the last year, the Operating Income growth was -348%. The average annual Operating Income growth rates for Avalon Globocare Corp have been -32% over the past three years , -3% over the past five years .

Back to Top